Skip to main content
SpringerLink
Log in

Cancer Vaccines

  • Protocol
Vaccine Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 4))

  • 521 Accesses

Abstract

In the past there was considerable evidence that cellular rather than antibody responses were more effective for tumor rejection (1). However, the task of identifying the tumor antigens recognized by T-cells was daunting technically. More recently there has been a growing optimism that the potential of tumor immunotherapy may at last be realized. This enthusiasm has been fed by a better understanding of the presentation and processing of peptides necessary for the induction of immune responses and the identification of new tumor targets. These developments will be discussed in this chapter. Because cancer vaccines are still in their infancy and largely experimental, detailed protocols for their production will not be presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Robins, R. A. (1986) T-cell responses at the host: tumour mterface. Bzochim Blophys Acta 856, 289–305.

    Google Scholar 

  2. Rletbmuller, G., Scbneidergadicke, E., Schllmok, G., Scbmiegel, W, Raab, R., Hofken, K., Gruber, R., Plchlmaier, H., Hirche, H., Pichlmayr, R., Bugguch, P., Witte, J., Elgler, F W., Fracklerschwalbe, I., Funke, I, Schmidt, C G., Scbrelber, H., Schweiberre, L., and Elbleibesfeldt, B. (1994) Randomized trial for monoclonal antibody for adjuvant therapy of resected dukes-C colorectal carcinoma. Lancet 343,8907, 1177–1183

    Article  Google Scholar 

  3. Van den Eynde, B., Lethe, B., Van Pel, A., De Plaen, E, and Boon, T. (1993) The gene for coding for a major rejection antigen of tumor P815 is identical to the gene of syngenelc DBAl2 mice. J Exp. Med. 173, 1373–1378.

    Article  Google Scholar 

  4. Gaugler, B., Vandeneynde, B., Vanderbruggen, P., Romero, P., Gaforio, J., Deplaen, E., Lethe, B., Brasseu, F., and Boon, T. (1994) Human gene MAGE3 codes for an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. J. Exp Med. 179, 921–930

    Article  PubMed  CAS  Google Scholar 

  5. Brichard, V., Vanpel, A., Wolfel, T., Wolfel, C., Deplaen, E., Lethe, B., Coulie, P., and Boon, T. (1993) The tyrosmase gene codes for an antigen recognized by auotologous cytolytlc T-lymphocytes on HlA-A2-melanomas. J. Exp. Med. 2, 489–495.

    Article  Google Scholar 

  6. Bakker, A. B., Scbreurs, M. W., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. (1994) Melanocyte lineage-specific antigen gp l00 is recogmsed by melanoma-denved tumour-infiltrating lymphocytes. J. Exp. Med. 179, 1005–1009.

    Article  PubMed  CAS  Google Scholar 

  7. Kawakami, Y., Ehyahu, S., Delgado, C. H., Robbms, P. F., Rivoltinin, L., Topahan, S. L., Mlki, T., and Rosenberg, S. A. (1994) Cloning of the gene coding for a shared human melanoma antigen recogmsed by autologous T cells infiltrating into tumour. Proc. Natl. Acad. Sci. USA 91, 3515–3519.

    Article  PubMed  CAS  Google Scholar 

  8. Mandelboim, O., Berke, G., Fridkm, M., Feldman, M., Eisenstein, M., and Elsenbach, L. (1994) CTL induction by a turnour-associated antigen octapeptlde derived from a murine lung carcinoma. Nature 369, 67–71.

    Article  PubMed  CAS  Google Scholar 

  9. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slmgluff, C. L., Jr. (1994) Identification of a peptide recognised by five melanoma-specific human cytotoxic T cell lines. Science 264, 716–719.

    Article  PubMed  CAS  Google Scholar 

  10. Henderson, R. A., Cox, A. L., Sakaguchi, K., Appella, E., Shabanowitz, J., Hunt, D. F., and Engelhard, V. H. (1993) Direct identification of an endogenous peptide recognised by multiple HLA-A2.1-specific cytotoxic T cells Proc. Natl. Acad Sci. USA 90, 10,275–10,279.

    Article  PubMed  CAS  Google Scholar 

  11. Topalian, S. L., Rivoltinin, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., and Rosenberg, S. A. (1994) Human CD4+ T cells specifically recognise a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA 91, 9461–9465.

    Article  PubMed  CAS  Google Scholar 

  12. Stuhler, G. and Walden, P. (1993) Collaboration of helper and cytotoxm T-lymphocytes. Eur. J. Immunol. 23, 2279–2286.

    Article  PubMed  CAS  Google Scholar 

  13. Shirai, M., Pendleton, C. D., Ahlers, J., Takeshita, T., Newman, M., and Berzofsky, J. A. (1994) Helper-cytotoxic T lymophocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J. immunol. 152, 549–556.

    PubMed  CAS  Google Scholar 

  14. Yanuck, M., Carbone, D. P., Pendleton, D. C., Tsukui, T., Winter, S. F., Minna, J. D., and Berzofsky, J. A. (1993) A mutant p53 tumour suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells. Cancer Res. 53, 3257–3261.

    PubMed  CAS  Google Scholar 

  15. Houbiers, J. G., Nigjman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J., Brand, A., Momburg, F., Kast, W. M., and Mehef, C J. (1993) In vitro induction of human cytotoxic T lymophocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol. 23, 2072–2077.

    Article  PubMed  CAS  Google Scholar 

  16. Peace, D. J., Chen, W., Nelson, H., and Cheever, M. A. (1991) T cell recognition of transforming proteins encoding by mutated ras proto-oncogenes. J. Immunol. 146, 2059–2065.

    PubMed  CAS  Google Scholar 

  17. Jung, S. and Schulesener, H. J. (1991) Human T lymophocytes recogmze a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 173, 273–276.

    Article  PubMed  CAS  Google Scholar 

  18. Fenton, R. G., Taub, D. D., Kwak, L. W., Smith, M. R., and Longo, D. L. (1993) Cytotoxic T-cell response and zn vivo protection against tumour cells harboring activated ras protooncogenes. J. Natl. Cancer Inst. 85, 1294–1301.

    Article  PubMed  CAS  Google Scholar 

  19. Townsend, A., Ohlen, C., Rogers, M., Edwards, J., Mukherjee, S., and Bastin, J. (1994) Source of unique tumour antigens. Nature 371, 662.

    Article  PubMed  CAS  Google Scholar 

  20. Chattopadhyay, P., Starkey, J., Morrow, W. J. W., and Raychaudhuri, S. (1992) Murine monoclonal anti-iodiotype antibody breaks unresponsiveness and induces a specific antibody response to human melanoma associated proteoglycan antigen in cynomolgus monkeys. Proc. Natl. Acad. Sci. USA 89, 2684–2688.

    Article  PubMed  CAS  Google Scholar 

  21. Durrant, L. G., Denton, G. W. L., Jacobs, E., Mee, M., Moss, R., Austin, E. G., Baldwin, R. W., Hardcastle, J. D., and Robins, R. A (1992) Anti-colorectal tumour cellular and humoral responses inducted by an idiotypic replica of carcmoembryomc antigen. Int. J. Cancer 50, 811–816.

    Article  PubMed  CAS  Google Scholar 

  22. Bashford, J. L., Robins, R. A., and Price, M. R. (1993) Development of an anti-iodiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core. Znt. J. Cancer 54, 778–783.

    Article  CAS  Google Scholar 

  23. Austm, E. B., Robins, R. A., Durrant, L. G., Price, M. R., and Baldwin, R. W. (1989) Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36. Immunology 67, 525–530.

    Google Scholar 

  24. Durrant, L. G., Doran, M., Austin, E. B., and Robins, R. A. (1995) Induction of cellular immune responses by a murme monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours. Int. J. Cancer. 61, 62–66.

    Article  PubMed  CAS  Google Scholar 

  25. Austin, E. B., Robms, R. A., Baldwin, R. W., and Durrant, L. G. (1991) Induction of delayed type hypersensitity to human tumour cells with a human monoclonal anti-idiotypic antibody. J. Natl. Cancer Inst. 83, 1245–1248.

    Article  PubMed  CAS  Google Scholar 

  26. Dun-ant, L. G., Byers, V. S., Scamon, P. J., Rodvien, R., Grant, K., Robins, R. A., Marksman, R. A., and Baldwm, R. W. (1989) Humoral nnmune responses to XMMCO-791 RTA immunotoxm in colorectal cancer paltents. Clzn. Exp. Immunol. 15, 258–264.

    Google Scholar 

  27. Robins, R. A., Denton, G. W. L., Hardcastle, J. D., Austm, E. B., Baldwin, R. W., and Durrant, L. G. (1991) Antitumor immune response and mterleukin 2 production inducted in colorectal cancer patients by immunization with human monoclonal anti-idiotype antibody. Cancer Res. 51, 5425–5429.

    PubMed  CAS  Google Scholar 

  28. Denton, G. W. L., Durrant, L. G., Hardcastle, J. D., Austin, E. B., Sewell, H. F., and Robins, R. A. (1994) Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int. J. Cancer 57, 10–14.

    Article  PubMed  CAS  Google Scholar 

  29. Williams, W. V., London, S. D., Werner, D. B., Wadsworth, S., Berzofsky, J. A., Robey, F., Rubin, D. H., and Greene, M. I. (1989) Immune response to a molecularly defined internal image idiotope. J, Immunol. 142, 4392–4400.

    CAS  Google Scholar 

  30. Chen, Z. J., Yang, H., Kageshita, R., and Ferrone, A. (1991) Human high-molecular-weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody Tk7-271. Cancer Res. 51, 4790–4797.

    PubMed  CAS  Google Scholar 

  31. Pohl, C., Renner, C., Schwonzen, M., Sieber, M., Lorenz, P., Pfreundschuh, M., and Diehl, V. (1992) Anti-idiotype vaccine against Hodgkins lymphoma-induction of B-cell and T-cell immunity across species barriers agamst Cd30 antigen by murme monoclonal internal image antibodies. Int. J. Cancer 50, 958–967.

    Article  PubMed  CAS  Google Scholar 

  32. Irvine, K. and Schlom, J. (1993) Induction of delayed type hypersensitivity responses by monoclonal antibodies to tumour-cells expressing carcmembryonic antigen and tumour associated glycoprotein-72. Cancer Immunol. Immunother. 36, 281–292.

    Article  PubMed  CAS  Google Scholar 

  33. Saleh, M S., Stapleton, J. D., Khazaeli, M. B., and LoBuglio, A. F. (1993) Generation of a human monoclonal anti-idiotype antibody that mimics the GD2 antigen. J. Immunol. 151, 2290–2298.

    Google Scholar 

  34. Pride, M. W., Shi, H., Anchin, J. M., Linthicum, D. S., LoVerde, P. T., Thakur, A., and Thanavala, Y. (1992) Molecular mimicry of hepatitis B surface antigen by an anti-idiotype derived synthetic peptide. Proc. Natl. Acad. Sci. USA 89, 11,900–11,904.

    Article  PubMed  CAS  Google Scholar 

  35. Raychaudhuri, S., Kang, C. Y., Kaveri, S. V., Kieber-Emmons, T., and Kohler, H. (1990) Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. J. Immunol. 145, 760–767.

    PubMed  CAS  Google Scholar 

  36. Durrant, L. G., Buckley, T. J. D., Denton, G. W. L., Hardcastle, J. D., Sewell, H. F., and Robins, R. A. (1994) Enhanced cell mediated tumour killing in patients unmunised with human monoclonal anti-idiotypic antibody 105AD7. Cancer Res. 54, 4837–4840.

    PubMed  CAS  Google Scholar 

  37. Barnd, D., Lan, M., Metzgar, R., and Firm, O. (1989) Specific MHC-unrestricted recognition of tumour associated mucins by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86, 7159–7163.

    Article  PubMed  CAS  Google Scholar 

  38. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadtmitriou, J., McKenzie, I. R., Bast, R. C., and Finn, O. J. (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recogmse an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51, 2908–2916.

    PubMed  CAS  Google Scholar 

  39. Jerome, K. R., Domenech, N., and Finn, O. J. (1992) Tumour-associated epitopes on Epstein-Barr virus-immortalised B-cells and Burkitt’s lymphomas transfected with epithelial mucin complementary DNA. Cancer Res. 52, 5985–5990.

    PubMed  CAS  Google Scholar 

  40. Jerome, K. R., Domenech, N., and Finn O. J. (1993) Tumour-specific cytatoxlc T lymphocyte clones from patients with breast and pancreatic adenocarcinoma recognise EBV-immortalised B cells transfected with polymorphic epithelial mucin cDNA. J. Immunol. 151, 1654–1662.

    PubMed  CAS  Google Scholar 

  41. Bu, D., Domenech, N., Lewis, J., Taylor-Papadimitriou, J., and Finn, O. J. (1993) Recombinant vaccinia mucin vector; in vztro analysis of expression of tumour-associated epitopes for antibody and human cytotoxic T-cell recognition. J. Immunother. 14, 127–135.

    Article  CAS  Google Scholar 

  42. Srivastava, P. K. (1993) Peptide-binding heat-shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv. Cancer Res. 62, 153–177.

    Article  PubMed  CAS  Google Scholar 

  43. Li, Z. and Srivastava, P. K. (1993) A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation. Behring Inst. Mitt. 35, 37–47.

    Google Scholar 

  44. Blachere, N. E., Udono, H., Janetzki, S., Li, Z., Heike, M., and Srivastava, P. K. (1993) Heat-shock protein vaccines against cancer. J. Immunother. 14, 352–356.

    Article  CAS  Google Scholar 

  45. Gruichard, G., Benkuane, N., Zeder-Lutz, G., van Regenmortel, M. H., Briand, J. P., and Muller, S. (1994) Antigenic mimicry of natural L-peptides with retroinverso peptidomimetws. Proc. Natl. Acad. Sci. USA 96, 9765–9769.

    Article  Google Scholar 

  46. Celis, E., Tsai, V., Crinn, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. (1994) Induction of anti-tumour cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91, 2105–2109.

    Article  PubMed  CAS  Google Scholar 

  47. Comy, R. M., Lobugbo, A. F., Kantor, J., Schlom, J., Loechel, F., Moore, S. E., Sumerel, L. A., Barlow, D. I., Abrams, S., and Curiel, D. T. (1994) Immune-response to a carcinoembryomc antigen polynucleotide vaccine. Cancer Res. 54, 1164–1168.

    Google Scholar 

  48. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., and Brose, K. (1993) Vaccmation with irradiated tumour cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumour immunity. Proc. Natl. Acad Sci. USA 90, 3539–3543.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, City Hospital, Nottingham, UK

    Lindy G. Durrant & T. J. Declan Buckley

Authors
  1. Lindy G. Durrant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. J. Declan Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre for Applied Microbiology and Research, Porton Down, UK

    Andrew Robinson , Graham H. Farrar  & Christopher N. Wiblin ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Humana Press Inc, Totowa, NJ

About this protocol

Cite this protocol

Durrant, L.G., Buckley, T.J.D. (1996). Cancer Vaccines. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:301

Download citation

  • DOI: https://doi.org/10.1385/0-89603-334-1:301

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-334-4

  • Online ISBN: 978-1-59259-588-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation